J Grøndahl-Hansen

6.0k total citations · 1 hit paper
40 papers, 5.4k citations indexed

About

J Grøndahl-Hansen is a scholar working on Cancer Research, Oncology and Hematology. According to data from OpenAlex, J Grøndahl-Hansen has authored 40 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cancer Research, 18 papers in Oncology and 18 papers in Hematology. Recurrent topics in J Grøndahl-Hansen's work include Protease and Inhibitor Mechanisms (32 papers), Peptidase Inhibition and Analysis (17 papers) and Blood Coagulation and Thrombosis Mechanisms (17 papers). J Grøndahl-Hansen is often cited by papers focused on Protease and Inhibitor Mechanisms (32 papers), Peptidase Inhibition and Analysis (17 papers) and Blood Coagulation and Thrombosis Mechanisms (17 papers). J Grøndahl-Hansen collaborates with scholars based in Denmark, Netherlands and Norway. J Grøndahl-Hansen's co-authors include Keld Danø, Lars Skriver, Lene Nielsen, Peter Lommer Kristensen, P.A. Andreasen, Elisabeth Ralfkiær, Peter Kristensen, Nils Brünner, Leif R. Lund and Ebbe Rønne and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and The EMBO Journal.

In The Last Decade

J Grøndahl-Hansen

40 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasminogen Activators, Tissue Degradation, and Cancer

1985 2.3k citations Keld Danø, P.A. Andreasen et al. Advances in cancer research profile →

Peers

Countries citing papers authored by J Grøndahl-Hansen

Since Specialization

Citations

This map shows the geographic impact of J Grøndahl-Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Grøndahl-Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Grøndahl-Hansen more than expected).

Fields of papers citing papers by J Grøndahl-Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Grøndahl-Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Grøndahl-Hansen. The network helps show where J Grøndahl-Hansen may publish in the future.

Co-authorship network of co-authors of J Grøndahl-Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of J Grøndahl-Hansen. A scholar is included among the top collaborators of J Grøndahl-Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Grøndahl-Hansen. J Grøndahl-Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Indirect Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Actinobacillus Pleuropneumoniae Serovar 7 in Pig Serum 2007 ·Journal of Veterinary Diagnostic Investigation ·Joan Klausen, (unknown), J Grøndahl-Hansen, Lars Ole Andresen	13
2	Development and evaluation of a mixed long-chain lipopolysaccharide based ELISA for serological surveillance of infection with Actinobacillus pleuropneumoniae serotypes 2, 6 and 12 in pig herds 2003 ·Veterinary Microbiology ·J Grøndahl-Hansen, Kristen Barfod, Joan Klausen, Lars Ole Andresen, Peter M. H. Heegaard, Vibeke Sørensen	13
3	Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients 1997 ·European Journal of Cancer ·Helle Pappot, Gunilla Høyer‐Hansen, Ebbe Rønne, Heine H. Hansen, Nils Brünner, Keld Danø, J Grøndahl-Hansen	67
4	Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry 1997 ·Lung Cancer ·Helle Pappot, Birgit Guldhammer Skov, Charles Pyke, J Grøndahl-Hansen	11
5	ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts 1997 ·International Journal of Cancer ·(unknown), Helle Pappot, Nils Brünner, J Grøndahl-Hansen, Gunilla Høyer‐Hansen, Niels Behrendt, (unknown), Fred C.G.J. Sweep, (unknown), Keld Danø	13
6	Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients 1997 ·Breast Cancer Research and Treatment ·J Grøndahl-Hansen, Susan G. Hilsenbeck, (unknown), Gary M. Clark, C. Kent Osborne, Nils Brünner	46
7	Presence of urokinase plasminogen activator, its inhibitor and receptor in small cell lung cancer and non-small cell lung cancer 1997 ·International Journal of Oncology ·Helle Pappot, Per Pfeiffer, J Grøndahl-Hansen, Mikael B. Skov	5
8	Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 Workshop 1996 ·European Journal of Cancer ·Th. J. Benraad, J Geurts-Moespot, J Grøndahl-Hansen, Manfred Schmitt, J.J.T.M. Heuvel, J Witte, John A. Foekens, R E Leake, Nils Brünner, Fred C.G.J. Sweep	57
9	The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria 1995 ·British Journal of Haematology ·Ebbe Rønne, Helle Pappot, J Grøndahl-Hansen, Gunilla Høyer‐Hansen, Torben Plesner, Niels Ebbe Hansen, Keld Danø	86
10	Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in Breast cancer 1994 ·Cancer treatment and research ·Nils Brünner, Charles Pyke, (unknown), John Rømer, J Grøndahl-Hansen, Keld Danø	27
11	High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. 1993 ·PubMed ·J Grøndahl-Hansen, I. J. Christensen, Christian Rosenquist, (unknown), H.T. Mouridsen, K Danø, M Blichert-Toft	353
12	Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. 1991 ·PubMed ·J Grøndahl-Hansen, Elisabeth Ralfkiær, Lene T. Kirkeby, Peter Kristensen, Leif R. Lund, Keld Danø	162
13	Tissue-type plasminogen activator in plasma from breast cancer patients determined by enzyme-linked immunosorbent assay 1990 ·British Journal of Cancer ·J Grøndahl-Hansen, (unknown), (unknown)	8
14	Urokinase- and Tissue-Type Plasminogen Activators in Keratinocytes During Wound Reepithelialization In Vivo 1988 ·Journal of Investigative Dermatology ·J Grøndahl-Hansen, Leif R. Lund, Elisabeth Ralfkiær, V Ottevanger, Keld Danø	206
15	Transforming growth factor‐β1 is a potent inducer of plasminogen activator inhibitor type‐1 in human glioblastoma and carcinoma cell lines 1988 ·Apmis ·Eirik Helseth, Are Dalen, Geirmund Unsgaard, Toril Skandsen, J Grøndahl-Hansen, Leif R. Lund	8
16	Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. 1986 ·Journal of Biological Chemistry ·P.A. Andreasen, Lene Nielsen, Peter Kristensen, J Grøndahl-Hansen, Lars Skriver, Keld Danø	208
17	Plasminogen Activators, Tissue Degradation, and Cancer breakdown → 1985 ·Advances in cancer research ·Keld Danø, P.A. Andreasen, J Grøndahl-Hansen, Peter Lommer Kristensen, Lene Nielsen, Lars Skriver	2301
18	Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland. 1985 ·The Journal of Cell Biology ·Peter Lommer Kristensen, Lene Nielsen, J Grøndahl-Hansen, (unknown), Lars Larsson, Keld Danø	56
19	Proenzyme to urokinase‐type plasminogen activator in the mouse in vivo 1985 ·FEBS Letters ·(unknown), P.A. Andreasen, J Grøndahl-Hansen, Lene Nielsen, Lars Skriver, Keld Danø	48
20	Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. 1984 ·The EMBO Journal ·P.A. Andreasen, Lene Nielsen, J Grøndahl-Hansen, Lars Skriver, Jesper Zeuthen, Ross W. Stephens, Keld Danø	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact